May. 14 at 12:39 AM
$OSTX With only 11 trading days left in May, the setup for OS Therapies Inc. is becoming difficult for the market to ignore.
As we inch closer to the pre-BLA meeting we’re starting to see the initial signs of our momentum starting to build. With a market cap still extremely compressed relative to oncology peers, even partial derisking could justify a move into the
$3-
$5 range, while a fully positive accelerated approval framework could rapidly push price discovery beyond that.
Institutions typically wait for regulatory clarity. A positive pre-BLA outcome could trigger new buying, momentum inflows, and short-term scarcity in the float all at once. The closer we get to the meeting without negative news, the stronger the probability that traders continue positioning ahead of the announcement, potentially driving the stock into the high-
$2S or low-
$3S even before official meeting results are released. In the next 1-4 weeks we could realistically see the stock price 1-4X. 📈—📈📈📈📈
